Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,660 across all filing types
Latest filing 2023-09-28 Declaration of Voting R…
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Please find attached voting results along-with scrutinizer''s report on the e-Voting for the 38th Annual General Meeting held on Thursday, 28th September 2023 through video conferencing ....
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is dated 28/09/2023 and is addressed to stock exchanges (NSE and BSE) regarding the voting results of the 38th Annual General Meeting (AGM) of Morepen Laboratories Limited. It details the voting process, including remote e-voting dates, the appointment of a scrutinizer, and the consolidated Scrutinizer's Report. The document includes detailed voting results for multiple resolutions passed at the AGM, such as adoption of financial statements, appointment and re-appointment of directors, ratification of remuneration, and approval of remuneration for the Chairman & Managing Director. The presence of detailed voting results and the context of the AGM clearly indicate this is a Declaration of Voting Results document. It is not an announcement of a report publication, nor a full annual report or management report. Therefore, the correct classification is Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (13,525 characters) and detailed content support a high confidence score.
2023-09-28 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is titled as the "Proceedings of 38th Annual General Meeting held on Thursday, September 28, 2023" and details the conduct of the AGM including the chairman's address, quorum, resolutions considered, and voting procedures. It explicitly states it is the gist of the proceedings of the AGM and not the minutes. The content focuses on the meeting's conduct and resolutions rather than financial data or full reports. The document length is 6843 characters, which is sufficient to contain detailed AGM proceedings. There is no indication that this is a full annual report, audit report, or earnings release. It is not a voting results announcement (DVA) since it does not provide final voting results but only the meeting proceedings. Therefore, the document fits best under AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including meeting proceedings.
2023-09-28 English
Please find attached proceedings of 38th Annual General Meeting of the Morepen Laboratories Limited held on Thursday, 28th September 2023 through video conferencing/ other audio visual means.
AGM Information Classification · 95% confidence The document is dated 28/09/2023 and is addressed to stock exchanges in India, referencing the 38th Annual General Meeting (AGM) of Morepen Laboratories Limited held on the same date via video conferencing. It details the proceedings of the AGM, including the chairman's address, quorum confirmation, agenda items such as adoption of audited financial statements for the fiscal year ended 31 March 2023, appointment and re-appointment of directors, and voting procedures. The document explicitly states it is the "Gist of the proceeding" of the AGM and not the minutes. It also mentions that the voting results will be separately intimated and published later. The content is a summary of the AGM proceedings rather than the full minutes or the actual financial report. The document length is 6832 characters, which is consistent with a detailed meeting proceeding summary. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the AGM or summaries of the meeting proceedings. It is not a full Annual Report (10-K), nor a voting results declaration (DVA), nor a report publication announcement (RPA). Therefore, the correct classification is AGM Information (AGM-R).
2023-09-28 English
Loss of Share Certificates
Regulatory Filings
2023-09-21 English
Please find attached details of loss of share certificates.
Regulatory Filings
2023-09-21 English
Loss of Share Certificates
Regulatory Filings
2023-09-20 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.